Accessibility settings

This paper is in the following e-collection/theme issue:

Cross-Sectional Studies in Public Health (1305) Public (e)Health, Digital Epidemiology and Public Health Informatics (2327) Public Health (384) Prevention and Health Promotion (2285) HIV/AIDS/STI Prevention and Care (1295) Precision Medicine and Genetics (107)

Published on in Vol 12 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/96139, first published .
Nurse offers pills to elderly man, recording medication details.

Genetic Subtypes, Pretreatment Drug Resistance, and Associated Factors Among Individuals Newly Diagnosed With HIV-1 in Zhejiang Province From 2022 to 2024: Cross-Sectional Study

Genetic Subtypes, Pretreatment Drug Resistance, and Associated Factors Among Individuals Newly Diagnosed With HIV-1 in Zhejiang Province From 2022 to 2024: Cross-Sectional Study

Authors of this article:

Wei Cheng1 ;   Qin Fan1 Author Orcid Image ;   Jiafeng Zhang1 Author Orcid Image ;   Jun Jiang1 Author Orcid Image ;   Jiezhe Yang1 ;   Yun Xu1 ;   Lin Chen1 Author Orcid Image ;   Chengliang Chai1 Author Orcid Image ;   Xiaohong Pan1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Wei Cheng   1 , MPH ;   Qin Fan   1 , MPH ;   Jiafeng Zhang   1 , MPH ;   Jun Jiang   1 , MPH ;   Jiezhe Yang   1 , MPH ;   Yun Xu   1 , MPH ;   Lin Chen   1 , MPH ;   Chengliang Chai   1 , MPH ;   Xiaohong Pan   1 , MPH

1 Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China

Corresponding Author:

  • Chengliang Chai, MPH
  • Zhejiang Provincial Center for Disease Control and Prevention
  • 3399 Binsheng Road, Binjiang District, Hangzhou, Zhejiang
  • Hangzhou 310051
  • China
  • Phone: 86 057187115191
  • Email: chlchai@cdc.zj.cn